A large population-based study found that statin use was significantly associated with a reduced risk of SAH. Research suggested potential clinical benefit to statins in this setting, particularly in ...

Globally, 1 in 4 people over 25 will have a stroke of some form, according to the World Stroke Organization. Subarachnoid hemorrhages account for approximately 1.2 million cases of stroke each year, ...

The effect of a liberal red-cell transfusion strategy as compared with a restrictive strategy in patients during the critical care period after an aneurysmal subarachnoid hemorrhage is unclear. We ...

Please provide your email address to receive an email when new articles are posted on . Moderate to severe angiographic vasospasm was detected more often in controls than in those given implants. At ...

Aneurysmal subarachnoid hemorrhage-related hydrocephalus (aSAH-H) is a clinical syndrome that leads to excessive accumulation of cerebrospinal fluid (CSF) and ventricle enlargement in the brain.

A Prescription Drug User Fee Act target date of April 23, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted orphan drug designation to NeurOp Inc. for an investigational candidate for treating ...

ATLANTA--(BUSINESS WIRE)--NeurOp, Inc., a clinical-stage biotechnology company focused on neurological and psychiatric disorders, today announced that the U.S. Food and Drug Administration (FDA) has ...

In a trial involving patients with subarachnoid hemorrhage and anemia, liberal transfusion of red cells did not result in a lower risk of an unfavorable neurologic outcome than a more restrictive ...